Preeclampsia y anticuerpos antifosfolípidos

  • Jorge Mario Gómez Jiménez
  • Natalia Aguirre Zimerman
  • Alejandro Quintero Galeano
  • Jader Gómez Gallego

Resumen

Presentamos una actualización del conocimiento acerca de la asociación entre la preeclampsia y los anticuerpos antifosfolípidos, con el ánimo de optimizar el enfoque diagnostico y terapéutico que ofrecemos a nuestras pacientes y sentar las bases que permitan plantear hipótesis para iniciar investigaciones que ayuden a los profesionales que responden por las enfermas a su mejor comprensión y atención.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Jorge Mario Gómez Jiménez
Profesor Asistente. Departamento de Obstetricia y Ginecología. Facultad de Medicina. Universidad de Antioquia.
Natalia Aguirre Zimerman
Residente de primer año. Departamento de Obstetricia y Ginecología. Facultad de Medicina. Universidad de Antioquia.
Alejandro Quintero Galeano
Residente de primer año. Departamento de Obstetricia y Ginecología. Facultad de Medicina. Universidad de Antioquia.
Jader Gómez Gallego
Residente de primer año. Departamento de Obstetricia y Ginecología. Facultad de Medicina. Universidad de Antioquia.

Referencias bibliográficas

E.U. Population Reference Bureau (PRB). Resumen de las conclusiones del Consejo Nacional de Investigación de la Academia Nacional de Ciencias de los E.U. "Cómo mejorar la salud reproductiva de los países en desarrollo". Washington. Oct 1997.

Presidencia de la República, Departamento Nacional de Planeación, Ministerio de Salud y otros. "Mortalidad Materna en Colombia". Santafé de Bogotá, Agosto 1996.

Williams Obstretrics, 20 edición, cap. 31, p. 693-744.

Creasy. Maternal-fetal medicine. cuarta edición, W. B. Saunders Company, cap. 48. Págs. 833-872.

Stone J. y cols. Risk factors for severe preeclampsia. Obstetrics and Gynecology. 1994; 83(3): 357-61.

Sibai B. Aspectos inmunitarios de la PE. Clínicas Obstétricas y Ginecológicas. 1991; 1: 27-33.

Branch D. y cols. The association of antiphospholipid antibodies with severe preeclampsia. Obstetrics and Gynecology. 1989; 73(4): 541-45.

Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective Studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstetrics and Gynecology. 1995; 86(4) parte 1: 555-59.

Gharavi A. Antiphospholipid Cofactor. Stroke. 1992; Supplement 1, 23(2) 1-7.

Faden D. y cols. anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-B2 glycoprotein I antibodies are associated with some obstetrical complications. mainly preeclampsia-eclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. 1997; 73: 37-421.

Lockwood Ch. Rand J. The Immunobiology and obstetrical consequences of antiphospholipid antibodies. Obst and Gynecology Survey. 1994; 49(6): 432-40.

Molina J. Anticuerpos Antifosfolípidos. IATREIA. 1992; 5(2): 160-1.

Lockwood CJ, Rand J, Schatzf y cols. Human placental anticoagulant protein: Isolation and characterization, Biochemistry. 1987; 26: 5572-5578.

Balasch J. Immunological factors in pregnancy wastage: True or fiction. En: Asch R and Studd J.(eds). Annual Progress in Reproductive Medicine, segunda edición, The Parthenon publishing group, Castherton Hall, Lancs, 1995; 117-138.

Silver R. y cols. Anticardiolipin antibodies: clinical consequences of "Low Titers". Obstetrics and Gynecology. 1996; 87(4): 494-500.

Lockwood C. y cols. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecology. 1989; 161(2): 369-73.

Harris E, Spinnato J. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecology. 1991; 165(5): part 1. 1272-77.

El-Roely A, Collicher N. Definition of normal autoantibody levels in apparently healthy population. Obst and Gynecology, 1988; 72: 596-602.

Fields RA. Toubbeh H Scarles RP. The Prevalence of the anticardiolipin antibodies in healthy elderly population and its association with antinuclear antibodies. J. Rheumatol. 1989; 16: 623-25.

The Anticardiolipin wet workshop. Fifth lnternational Symposium on Antiphospholipid Antibodies, San Antonio, Sept 13, 1992.

Oshiro B. Antiphospholipid antibodies and fetal death. Obstetrics and Gynecology. 1996; 87(4): 489-92.

Polzin W, Kopelman J, Robinson R, Read J, Brady K. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstetrics and Gynecology. 1991; 78(6): 1108-11.

Petri M, Rheinschmidt M, Whitting-O'Keete Q, Hellmann D. Corash L. The frequency of lupus anticoagulant in systemic lupus erytemathosus. Ann Intern Med 1987; 106: 524-531.

Matsuura E, Igarashi Y, Fujimoto M, Koike T. Improved enzyme immunoassay for anticardiolipin antibody: a highly specific assay for antiphospholipid syndrome. Clin Exp Rheumatol 1990; 8: 204.

Galli M y cols. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. The Lancet. 1990; 335: 1544-47.

Matsuura E, Igarashi Y, Fujimoto M, et al. Heterogeneity anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol. 1992; 148: 3885-91.

Katano I y cols. B2-Glycoprotein I dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Human Reproduction. 1996; 11(3): 509-12.

Aoki K, Matsuura E, Sasa H, Dudkiewicz AB and Gleicher N. B2-Glycoprotein I-dependent and independent anticardiolipin antibodies in healthy pregnant women. Hum Reprod. 1994; 9: 1849-1851.

Roberts JM, Redeman C. Pre-eclampsia: more than pregnancy induced hypertension. Lancet. 1993; 341: 1447-51.

La Rosa L. y cols. B2-Glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J. Rheumatol 1994; 21: 1684-93.

Del Papa N y cols. Relationship between antiphospholipid and endothelial cell antibodies III: B2 Glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion rnolecules. Clin Exp Rheumatol. 1995; 13: 179-85.

Del Papa N et al. Human monoclonal antibodies react in vitro with endothelial cells through the adhered 132 Glycoprotein I and induce endothelial cell activation. Arthr Rheum. 1995; 38: S390 (abst. 1420).

Drenakard C, et al. Fall in antiphospholipid antibody at time of thromoocclusive episodes in systemic lupus erithematosus. J Rheumatol 1989; 16: 6147.

Publicado
2000-09-29
Cómo citar
1.
Gómez Jiménez JM, Aguirre Zimerman N, Quintero Galeano A, Gómez Gallego J. Preeclampsia y anticuerpos antifosfolípidos. Rev. Colomb. Obstet. Ginecol. [Internet]. 29 de septiembre de 2000 [citado 22 de octubre de 2020];51(3):179-83. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/679
Sección
Revisión de Tema